Overview
Sergio Fazio is an Endocrinologist and a Cardiologist in Portland, Oregon. Dr. Fazio has been practicing medicine for over 37 years and is rated as an Advanced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are High Cholesterol, Familial Hypertriglyceridemia, Familial Hypercholesterolemia, and Atherosclerosis.
His clinical research consists of co-authoring 296 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Homozygous Familial Hypercholesterolemia (HoFH).
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
University Professional Services
Paul Duell is an Endocrinologist in Portland, Oregon. Dr. Duell is rated as a Distinguished provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Familial Hypercholesterolemia, Homozygous Familial Hypercholesterolemia (HoFH), Defective Apolipoprotein B-100, and Heterozygous Familial Hypercholesterolemia (HeFH).
University Professional Services
Jeffrey Marbach is a Cardiologist and an Interventional Cardiologist in Portland, Oregon. Dr. Marbach is rated as an Advanced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Cardiogenic Shock, Heart Attack, Homozygous Familial Hypercholesterolemia (HoFH), Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery. Dr. Marbach is currently accepting new patients.
University Professional Services
Jonathan Purnell is an Endocrinologist in Beaverton, Oregon. Dr. Purnell is rated as an Advanced provider by MediFind in the treatment of Homozygous Familial Hypercholesterolemia (HoFH). His top areas of expertise are Obesity, Type 2 Diabetes (T2D), Obesity in Children, Gastric Bypass, and Hormone Replacement Therapy (HRT).
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- High CholesterolDr. Fazio isElite. Learn about High Cholesterol.
- Distinguished
- AtherosclerosisDr. Fazio isDistinguished. Learn about Atherosclerosis.
- Familial HypercholesterolemiaDr. Fazio isDistinguished. Learn about Familial Hypercholesterolemia.
- Familial HypertriglyceridemiaDr. Fazio isDistinguished. Learn about Familial Hypertriglyceridemia.
- Heterozygous Familial Hypercholesterolemia (HeFH)
- Advanced
- Abdominal Aortic Aneurysm (AAA)Dr. Fazio isAdvanced. Learn about Abdominal Aortic Aneurysm (AAA).
- Acute Coronary SyndromeDr. Fazio isAdvanced. Learn about Acute Coronary Syndrome.
- Apolipoprotein C2 DeficiencyDr. Fazio isAdvanced. Learn about Apolipoprotein C2 Deficiency.
- Coronary Heart DiseaseDr. Fazio isAdvanced. Learn about Coronary Heart Disease.
- Defective Apolipoprotein B-100Dr. Fazio isAdvanced. Learn about Defective Apolipoprotein B-100.
- Familial Lipoprotein Lipase Deficiency
- Experienced
- Abdominal Obesity Metabolic SyndromeDr. Fazio isExperienced. Learn about Abdominal Obesity Metabolic Syndrome.
- Familial HypobetalipoproteinemiaDr. Fazio isExperienced. Learn about Familial Hypobetalipoproteinemia.
- Heart AttackDr. Fazio isExperienced. Learn about Heart Attack.
- Heart FailureDr. Fazio isExperienced. Learn about Heart Failure.
- High Molecular Weight Kininogen Deficiency
- Hyperlipidemia Type 3Dr. Fazio isExperienced. Learn about Hyperlipidemia Type 3.